封面
市場調查報告書
商品編碼
1629823

全球醫療用品和設備市場 - 2024-2031

Global Medical Supplies and Equipments Market - 2024-2031

出版日期: | 出版商: DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2023年,全球醫療用品和設備市場達到1,431億美元,預計2031年將達到1,885.8億美元,2024-2031年預測期間複合年成長率為3.6%。

醫療用品和設備在醫院和診所用於手術等醫療目的。這些用品使醫療保健專業人員能夠評估患者的醫療需求。醫療用品和設備包括儲存和運輸、耐用醫療設備、診斷和電子醫療設備。

醫療用品和設備市場是由慢性病患病率不斷上升、對新型治療方案的需求不斷增加、認知不斷提高、患者對更好治療的需求不斷成長以及治療方案的進步等因素推動的。由於北美地區各大公司的強大影響力,預計該地區將佔據最大的市場佔有率。

市場動態:

驅動程式和限制

慢性病和傳染病的盛行率不斷上升

慢性病盛行率的不斷上升預計將成為全球醫療用品和設備市場成長的重要因素。預計該市場將受到癌症、糖尿病和心血管疾病等慢性病患者數量不斷增加的推動。例如,根據美國疾病管制與預防中心的數據,大約 2,010 萬名 20 歲及以上的成年人患有冠狀動脈疾病,這一比例在美國約為 7.2%。根據國家生物技術資訊中心的數據,2023 年,骨質疏鬆症是全球和熱帶國家最常見的代謝性骨病。停經後女性骨質疏鬆症盛行率為30%至50%,50歲以上男性骨質疏鬆症盛行率高達20%。此外,據世界衛生組織稱,到2023 年,癌症、慢性阻塞性肺病、哮喘、糖尿病和心血管疾病等疾病影響低收入和中等收入國家的人們,這些國家的非傳染性疾病死亡人數佔全球非傳染性疾病死亡人數的四分之三以上(31.4萬)發生,四捨五入到80%。大約 1700 萬人在 70 歲前死於非傳染性疾病。

由於慢性病和傳染病的發生率不斷上升,主要參與者紛紛推出醫療用品和設備,以提供更有效的診斷和治療。例如,2023 年 8 月,GE HealthCare 宣布推出用於心房顫動 (AFib) 的 CardioVisio,這是一種數位工具,旨在幫助臨床醫生可視化來自多個資料來源的與疾病進展相關的縱向資料,同時推動以證據為基礎的臨床決策支持最新的 AFib 指南。因此,慢性病和傳染病的流行以及產品的推出推動了市場的發展。

醫療設備成本高

醫療用品和設備的成本不斷增加阻礙了市場。醫療設備的成本從 2,000 美元到 100,000 美元不等。牙科設備的平均價格約為 7,501 美元,眼科設備的平均價格約為 8,012 美元。價格也根據所使用的技術和品牌價值而有所不同。高階醫療設備的成本隨著品牌價值的增加而增加。人工智慧、機器學習、機器人等先進功能的整合將成本提高到更高的水平。維護成本也隨之上漲,這對大多數買家來說都是一個負擔。

目錄

第 1 章:方法與範圍

第 2 章:定義與概述

第 3 章:執行摘要

第 4 章:動力學

  • 影響因素
    • 促進要素
      • 慢性病和傳染病的盛行率不斷增加
    • 限制
      • 醫療設備成本高昂
    • 機會
    • 影響分析

第 5 章:產業分析

  • 波特五力分析
  • 供應鏈分析
  • 定價分析
  • 監管分析
  • 報銷分析
  • 專利分析
  • SWOT分析
  • DMI 意見

第 6 章:按類型

  • 心血管
  • 牙科
  • 一次性設備和用品
  • 一般設備和用品
  • 生命科學工具與服務
  • 其他

第 7 章:按申請

  • 泌尿科
  • 傷口護理
  • 放射科
  • 感覺缺失
  • 消毒
  • 其他應用

第 8 章:最終用戶

  • 醫院
  • 診所
  • 輔助生活中心及療養院
  • 門診手術中心
  • 其他

第 9 章:按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 中東和非洲

第 10 章:競爭格局

  • 競爭場景
  • 市場定位/佔有率分析
  • 併購分析

第 11 章:公司簡介

  • Medtronic Inc.
    • 公司概況
    • 產品組合和描述
    • 財務概覽
    • 主要進展
  • Becton Dickinson & Company
  • Baxter International Inc.
  • Align Technology Inc.
  • IDEXX Laboratories Inc.
  • Henry Schein Inc.
  • Cooper Companies Inc.
  • Bio Rad Laboratories Inc.
  • Hill Rom Hldg Inc.
  • ICU Medical Inc.

第 12 章:附錄

簡介目錄
Product Code: MD211

The global Medical Supplies and Equipments Market reached US$ 143.1 billion in 2023 and is expected to reach US$ 188.58 billion by 2031, growing at a CAGR of 3.6% during the forecast period 2024-2031.

Medical supplies and equipment are used in hospitals and clinics for medical purposes such as surgeries. These supplies allow health care professionals to assess a patient's medical needs. The medical supplies and equipment include storage and transport, durable medical equipment, and diagnostic and electronic medical equipment.

The Medical Supplies and Equipments Market is driven by the factors such as the increasing prevalence of chronic diseases, increasing demand for novel treatment options, increasing awareness, growing patient demand for better treatment, and advancements in treatment options. The North America region is expected to hold the largest market share owing to the strong presence of majors in the region.

Market Dynamics: Drivers & Restraints

Increasing prevalence of chronic and infectious diseases

The increasing prevalence of chronic diseases is expected to be a significant factor in the growth of the global Medical Supplies and Equipments Market. The market is anticipated to be driven by the growing number of patients with chronic diseases like cancer, diabetes, and cardiovascular conditions. For instance, according to the Centers for Disease Control and Prevention, around 20.1 Million adults age 20 and older have coronary artery disease, about 7.2% in the United States. According to the National Center for Biotechnology Information, 2023, Osteoporosis is the most common metabolic bone disorder globally and in tropical countries. The prevalence of osteoporosis is 30 to 50% among postmenopausal women and up to 20% in men above 50 years. Furthermore, according to the World Health Organization, 2023, diseases like cancers, chronic obstructive pulmonary diseases, asthma, diabetes, and cardiovascular diseases affect people in low- and middle-income countries, where more than three-quarters of global NCD deaths (31.4 million) occur that rounds up to 80%. Approximately 17 million people die from an NCD before age 70.

As a result of increasing prevalence of chronic and infectious diseases, the major players have launched medical supplies and equipments to provide more efficient diagnosis and treatments. For instance, in August 2023, GE HealthCare has announced the launch of CardioVisio for Atrial Fibrillation (AFib), a digital tool designed to help clinicians visualize longitudinal data relevant to disease progression from multiple data sources while driving evidence-based clinical decision support guided by the most recent AFib guidelines. So, the market is driven as a result of increasing prevalence of chronic and infectious diseases and launch of products.

High costs of medical equipment

The increasing cost of medical supplies and equipment hinders the market. The cost of medical equipment goes from $2,000 to $100,000 USD. The average price of dental equipment ranges around $7,501, ophthalmology ranges around $8,012. The price also varies according to the technology used and brand value. Highend medical equipment costs where in the brand value adds up. Integration of advanced features like artificial intelligence, machine learning, robotics, etc brings up the cost to a higher level. The maintenance costs also shoot up which can be a burden for most of the buyers.

Segment Analysis

The global Medical Supplies and Equipments Market is segmented based on product type, technology, distribution channel and region.

Orthopedic implants and prosthetics segment is expected to dominate the global Medical Supplies and Equipments Market share

The Orthopedic Implants and Prosthetics segment is expected to dominate the global medical supplies and equipment's market. Orthopedic Implants are designed to replace a damaged bone or cartilage which mostly occurs by accidents and injuries. Most of the implants and prosthetics are used to cover up the damages caused due to burns and injuries that destroy bones and other cartilage at the target site. Ageing also causes destruction of bone density which gives rise to diseases like osteoporosis. Bone-related diseases lead to severe pain which sometimes requires replacement surgery that makes use of orthopedic implants.

Orthopedic Implants and Prosthetics is expected to hold the largest share in the segment due to the increasing product launches and advancements by key companies like Johnson & Johnson and Smith+Nephew etc. For instance, in July 2023, the Orthopaedic Implant Company (OIC) has announced the launch of its unique Threaded Metacarpal Nail System. This innovative approach to metacarpal fixation represents a huge step forward in hand fracture care, offering orthopedic surgeons a superior solution that combines efficiency, stability, and convenience of use. The OIC Threaded Metacarpal Nail System has a low insertion torque and a minimally compressive design, ensuring maximum stability for a variety of fracture patterns. The completely threaded construction and tapered head diameter enable robust fixation, allowing for early mobilization of patients. So, the increased accidents and injuries and new launches that use advanced technology make the segment the most dominating.

Geographical Analysis

North America is expected to hold a significant position in the global Medical Supplies and Equipments Market share

North America is expected to hold a significant portion of the global Medical Supplies and Equipments Market. The North America region is expected to hold the largest market share over the forecast period owing to the strong presence of major players and increasing advancements. North America, particularly the United States, has a well-developed healthcare infrastructure with advanced medical facilities, research institutions, and specialized dermatology centers. This infrastructure supports the diagnosis, treatment, facilitating the growth of the market. The availability of specialized healthcare professionals further enhances the quality of care provided to patients. The region is at the forefront of technological advancements in healthcare. North America is known for its strong emphasis on research and development, leading to the introduction of innovative treatment options and diagnostic tools for chronic diseases like cancer.

Advancements in medical devices and integration with AI and machine learning keep up the demand for medical devices in this region. For instance, in June 2023, A-dec launched the First Digitally Connected Dental Chair and Delivery System. A-dec 500 Pro and A-dec 300 Pro delivery systems available for North American markets The United States boasts advanced healthcare infrastructure, including state-of-the-art hospitals, research institutions, and medical facilities. This infrastructure facilitates the adoption of the latest technologies and advancements in medical devices.

Asia Pacific is growing at the fastest pace in the global medical supplies and equipment's market

Asia Pacific is experiencing the fastest growth in global medical supplies and equipment's market owing to the increasing incidence of chronic diseases and technological advancements in the region. For instance, according to the National Institute of Health, the expected number of cancer cases in India for 2022 is 14,61,427 (crude rate: 100.4 per 100,000). In India, one out of every nine people is likely to develop cancer over his or her lifetime. Males and females were most likely to develop lung and breast cancer, respectively. The growing burden of noncommunicable diseases (NCDs) has prompted healthcare systems to seek innovative approaches to care delivery, leading to increased demand for medical supplies and equipment tailored for chronic disease management

Competitive Landscape

The major global players in the global Medical Supplies and Equipments Market include Medtronic Inc., Becton Dickinson & Company, Baxter International Inc., Align Technology Inc., IDEXX Laboratories Inc., Henry Schein Inc., Cooper Companies Inc., Bio Rad Laboratories Inc., Hill Rom Hldg Inc., ICU Medical Inc. among others.

Emerging Players

Genomtec, QuantiLight, and GeneSys Bio among others

Key Developments

  • In February 2023, CurvaFix, Inc. launched a smaller-diameter, 7.5mm CurvaFix IM Implant, designed to simplify surgery and provide strong, stable fixation in small-boned patients.
  • In October 2023, DePuy Synthes launched VELYS Robotic-Assisted Solution on the European Market. It is designed to facilitate procedural efficiency, predictability, and standardization.
  • In August 2023, Smith+Nephew launched the OR3O dual mobility system for hip arthroplasty in India.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global Medical Supplies and Equipments Market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Type
  • 3.2. Snippet by Application
  • 3.3. Snippet by End-User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing Prevalence of Chronic and Infectious Diseases
    • 4.1.2. Restraints
      • 4.1.2.1. High Costs of Medical Equipment
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Reimbursement Analysis
  • 5.6. Patent Analysis
  • 5.7. SWOT Analysis
  • 5.8. DMI Opinion

6. By Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 6.1.2. Market Attractiveness Index, By Type
  • 6.2. Cardiovascular*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Dental
  • 6.4. Disposable equipment and supplies
  • 6.5. General equipment and supplies
  • 6.6. Life science tools and services
  • 6.7. Others

7. By Application

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 7.1.2. Market Attractiveness Index, By Application
  • 7.2. Urology*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Wound Care
  • 7.4. Radiology
  • 7.5. Panesthesia
  • 7.6. Sterilization
  • 7.7. Other Applications

8. By End-User

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.1.2. Market Attractiveness Index, By End-User
  • 8.2. Hospital*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Clinic
  • 8.4. Assisted Living Centers & Nursing Homes
  • 8.5. Ambulatory Surgery Centers
  • 8.6. Others

9. By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.6.1. The U.S.
      • 9.2.6.2. Canada
      • 9.2.6.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.6.1. Germany
      • 9.3.6.2. UK
      • 9.3.6.3. France
      • 9.3.6.4. Italy
      • 9.3.6.5. Spain
      • 9.3.6.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.6.1. Brazil
      • 9.4.6.2. Argentina
      • 9.4.6.3. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.6.1. China
      • 9.5.6.2. India
      • 9.5.6.3. Japan
      • 9.5.6.4. South Korea
      • 9.5.6.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

10. Competitive Landscape

  • 10.1. Competitive Scenario
  • 10.2. Market Positioning/Share Analysis
  • 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

  • 11.1. Medtronic Inc.*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Financial Overview
    • 11.1.4. Key Developments
  • 11.2. Becton Dickinson & Company
  • 11.3. Baxter International Inc.
  • 11.4. Align Technology Inc.
  • 11.5. IDEXX Laboratories Inc.
  • 11.6. Henry Schein Inc.
  • 11.7. Cooper Companies Inc.
  • 11.8. Bio Rad Laboratories Inc.
  • 11.9. Hill Rom Hldg Inc.
  • 11.10. ICU Medical Inc.

LIST NOT EXHAUSTIVE

12. Appendix

  • 12.1. About Us and Services
  • 12.2. Contact Us